Sections

Weather Forecast

Close
Advertisement

FDA OKs start of BrainStorm stem cell trial in ALS patients

Email

TEL AVIV — BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration approved the start of a mid-stage clinical trial of its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS).

The Phase II trial will be launched initially at Massachusetts General Hospital in Boston and the University of Massachusetts Memorial Hospital in Worcester.

Are you a newspaper subscriber but you don't have a Digital Access account yet? https://secure.forumcomm.com/?publisher_ID=40&event=subscriber/lookup.

You will need your subscription account number and phone number. Not sure if you have an account? Email us at subscriberservices@forumcomm.com and we can help you.

Advertisement
Advertisement
Advertisement